Evidence map›Paper›PMID 26107350›Full record

ArticleVirulence2015

Galleria mellonella as a host model to study Aspergillus terreus virulence and amphotericin B resistance.

Elisabeth Maurer, Niall Browne, Carla Surlis, Emina Jukic, Patrizia Moser, Kevin Kavanagh, Cornelia Lass-Flörl, Ulrike Binder

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Virulence ofVirulence · 2026
    Article
  3. Article
  4. Article
  5. Journal of fungi (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Article
  8. Pathogens (Basel, Switzerland) · 2024
    Review
  9. Surveillance of Amphotericin B and Azole Resistance inJournal of fungi (Basel, Switzerland) · 2023
    Article
  10. The VirtuousAntibiotics (Basel, Switzerland) · 2023
    Review
  11. Antimicrobial agents and chemotherapy · 2022
    Article
  12. Microbiology spectrum · 2022
    Article
  13. Frontiers in fungal biology · 2022
    Review
  14. Frontiers in cellular and infection microbiology · 2022
    Article
  15. Synergistic effect of pyrvinium pamoate and posaconazole againstFrontiers in cellular and infection microbiology · 2022
    Article
  16. In Vivo Efficacy of Voriconazole in aJournal of fungi (Basel, Switzerland) · 2021
    Article
  17. Review
  18. Studies in mycology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Elisabeth Maurera Division of Hygiene and Medical Microbiology; Medical University of Innsbruck ; Innsbruck , Austria.
Niall Browneb Medical Mycology Unit; Department of Biology; Maynooth University ; Maynooth ; Kildare , Ireland.
Carla Surlisb Medical Mycology Unit; Department of Biology; Maynooth University ; Maynooth ; Kildare , Ireland.
Emina Jukica Division of Hygiene and Medical Microbiology; Medical University of Innsbruck ; Innsbruck , Austria.
Patrizia Moserc Department of Pathology ; Medical University of Innsbruck ; Innsbruck , Austria.
Kevin Kavanaghb Medical Mycology Unit; Department of Biology; Maynooth University ; Maynooth ; Kildare , Ireland.
Cornelia Lass-Flörla Division of Hygiene and Medical Microbiology; Medical University of Innsbruck ; Innsbruck , Austria.
Ulrike Bindera Division of Hygiene and Medical Microbiology; Medical University of Innsbruck ; Innsbruck , Austria.
Universität Innsbruck · ATNational University of Ireland, Maynooth · IEInnsbruck Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate if the alternative in vivo model Galleria mellonella can be used (i) to determine differences in pathogenicity of amphotericin B (AMB) resistant and susceptible A. terreus isolates, (ii) to evaluate AMB efficacy in vivo (iii) and to correlate outcome to in vitro susceptibility data. Larvae were infected with 2 A. terreus AMB resistant (ATR) and 3 AMB susceptible (ATS) isolates and survival rates were correlated to physiological attributes and killing ability of larval haemocytes. Additionally, infected larvae were treated with different concentrations of L-AMB. Haemocyte density were ascertained to evaluate the influence of L-AMB on the larval immune cells. Larvae were sensitive to A. terreus infection in an inoculum-size and temperature dependent manner. In vitro susceptibility to L-AMB correlated with in vivo outcome of antifungal treatment, defining an AMB susceptible strain cluster of A. terreus. Susceptibility to L-AMB increased virulence potential in the larval model, but this increase was also in accordance with faster growth and less damage caused by larval haemocytes. L-AMB treatment primed the larval immune response by increasing haemocyte density. G. mellonella provides a convenient model for the in vivo screening of A. terreus virulence and treatment options, contributing to the generation of a hypothesis that can be further tested in refined experiments in mammalian models.

Indexed as

Drug Resistance, FungalAmphotericin BAnimalsAntifungal AgentsAspergillusDisease Models, AnimalHemocytesLarvaLepidopteraSurvival AnalysisTreatment OutcomeVirulenceAmphotericin BAntifungal Agentsamphotericin B resistant and susceptible A. terreus strain clusterGalleria mellonellainvertebrate in vivo model

Identifiers

PMID26107350
PMCPMC4720272
OpenAlexW1925286893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.